CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 76 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,679 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -80.0% | 1,679 | -69.8% | 0.00% | -100.0% |
| Q1 2023 | $5 | -44.4% | 5,552 | -97.6% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 227,752 | -1.1% | 0.00% | -100.0% |
| Q3 2022 | $34,000 | +100.0% | 230,252 | +2.1% | 0.00% | +100.0% |
| Q2 2022 | $17,000 | -84.8% | 225,500 | -22.7% | 0.00% | -83.3% |
| Q1 2022 | $112,000 | +86.7% | 291,700 | +130.7% | 0.01% | +100.0% |
| Q4 2021 | $60,000 | -28.6% | 126,416 | -35.5% | 0.00% | -25.0% |
| Q3 2021 | $84,000 | +171.0% | 196,100 | +410.7% | 0.00% | +100.0% |
| Q2 2021 | $31,000 | – | 38,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |